Viking Therapeutics Stock Dips Despite Broader Market Gains Despite Recent Outperformance
• Viking Therapeutics (VKTX) stock closed 1.59% lower despite broader market gains • The stock has risen 8.54% over the past month, outpacing sectors and indexes • VKTX is forecasted to post an 8% drop in upcoming quarterly EPS • Analyst estimate revisions are correlated with near-term share price changes • Zacks Investment Research provides stock analysis and recommends 7 top stocks monthly